Literature DB >> 3291094

Late-onset schizophrenia: an overview.

M J Harris1, D V Jeste.   

Abstract

Onset of schizophrenia after the age of 40 has been a controversial topic. We reviewed more than 30 publications (mainly from Europe) on this subject. Many of the studies had methodological shortcomings, including problems in precisely dating the onset of schizophrenia. Nonetheless, it appears that a certain proportion of patients present for the first time with diagnosable schizophrenia after age 40. Late-onset schizophrenia is characterized by paranoid symptomatology, a high female:male ratio, an elevated prevalence of hearing loss and ocular pathology, schizoid or paranoid traits in premorbid personality, a tendency toward chronicity, and symptomatic improvement with neuroleptics. Family studies suggest that the prevalence of schizophrenia in relatives of late-onset schizophrenic probands is higher than that in the general population, but lower than that in relatives of earlier-onset schizophrenic probands. We believe that late-onset schizophrenia is a valid entity (or group of entities). Studies of the course, biological associations, neuropsychological performance, and pharmacological characterization of late-onset schizophrenia are warranted.

Entities:  

Mesh:

Year:  1988        PMID: 3291094     DOI: 10.1093/schbul/14.1.39

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  33 in total

Review 1.  Late-onset schizophrenia: epidemiology, diagnosis, management and outcomes.

Authors:  P A Wynn Owen; D J Castle
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 2.  Antipsychotic treatment for late-life schizophrenia.

Authors:  Jeremy A Sable; Dilip V Jeste
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

3.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.

Authors:  Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard
Journal:  Schizophr Bull       Date:  2013-08-31       Impact factor: 9.306

Review 4.  Psychotic symptoms in frontotemporal dementia.

Authors:  Devin Hall; Elizabeth C Finger
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 5.  Sleep Disturbances in the Elderly Patient with Inflammatory Bowel Disease.

Authors:  Taha Qazi; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

6.  Uprooting and late-life psychosis.

Authors:  T Fuchs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 7.  Long-acting injectable antipsychotics in the elderly: guidelines for effective use.

Authors:  Prakash S Masand; Sanjay Gupta
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia.

Authors:  Dhiren Singh; Daniel W O'Connor
Journal:  Clin Interv Aging       Date:  2009-09-01       Impact factor: 4.458

9.  Neurodevelopmental theories of schizophernia : application to late-onset schizophernia.

Authors:  B W Palmer; D V Jeste
Journal:  Indian J Psychiatry       Date:  1996-01       Impact factor: 1.759

10.  Phenomenological study of late-onset schizophrenia.

Authors:  M G Harish; K P Suresh; I Rajan; Y C Reddy; S Khanna
Journal:  Indian J Psychiatry       Date:  1996-10       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.